Steven Abramson

Steven Abramson, MD, is a prominent academic leader at the NYU Grossman School of Medicine. He holds the dual roles of Chair of the Department of Medicine and Frederick H. King Professor of Internal Medicine, alongside serving as Chief Academic Officer and Executive Vice President and Vice Dean for Education, Faculty, and Academic Affairs. His academic appointments include Professorships in the Department of Medicine and Department of Pathology.

Dr. Abramson graduated with an MD from Harvard Medical School. His research focuses on immunology, arthritis, and medical education innovation, with notable work on cytokine regulation in infectious diseases, proteomic biomarkers for osteoarthritis, and AI-driven medical admissions algorithms. He leads clinical trials investigating arthritis pathogenesis, SARS-CoV-2 immunology, and survivorship studies for ICU patients.

His publications span transformative education models (e.g., accelerated MD programs) and translational medicine. Collaborations include studies on intestinal microbiome impacts on rheumatoid arthritis and the role of IL1RN gene variants in cytokine storm syndromes.

Dr. Abramson’s administrative roles emphasize educational excellence and faculty development, driving initiatives in curriculum design and interdisciplinary research. He oversees the Rheumatology SAMPLE Registry and COVID-19 Survivorship Database, fostering data-driven clinical insights.